| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
|
Weishaupt, Carsten
|
|
2016
|
3 |
2 |
p. e72-e79
nvt p.
|
article
|
| 2 |
Catheter-directed thrombolysis: is it worth the risk?
|
Zack, Chad J
|
|
2016
|
3 |
2 |
p. e54-e55
nvt p.
|
article
|
| 3 |
Crowdsourcing biologicals
|
The Lancet Haematology,
|
|
2016
|
3 |
2 |
p. e53-
1 p.
|
article
|
| 4 |
Discontinuation therapy: the role of emotion and cognition
|
Riva, Silvia
|
|
2016
|
3 |
2 |
p. e63-
1 p.
|
article
|
| 5 |
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis
|
Conter, Valentino
|
|
2016
|
3 |
2 |
p. e80-e86
nvt p.
|
article
|
| 6 |
New hope for patients with livedoid vasculopathy
|
Kirsner, Robert S
|
|
2016
|
3 |
2 |
p. e56-e57
nvt p.
|
article
|
| 7 |
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
|
Haig, Ylva
|
|
2016
|
3 |
2 |
p. e64-e71
nvt p.
|
article
|
| 8 |
Safety and current status of blood transfusion in China: an update
|
Yu, Xuerong
|
|
2016
|
3 |
2 |
p. e60-e62
nvt p.
|
article
|
| 9 |
Search continues for a CMV vaccine for transplant recipients
|
Boeckh, Michael
|
|
2016
|
3 |
2 |
p. e58-e59
nvt p.
|
article
|
| 10 |
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
|
Nakamura, Ryotaro
|
|
2016
|
3 |
2 |
p. e87-e98
nvt p.
|
article
|
Journal description